Holen Sie sich die Stockscreener-App
53.75
1.52%
-0.83
Handel nachbörslich:
54.31
0.56
+1.04%
Structure Therapeutics Inc Adr Aktie (GPCR) Neueste Nachrichten
Why Structure Therapeutics (GPCR) Is Down 7.6% After Swinging to Q4 Profit and Filing a $236M Shelf RegistrationAnd What's Next - Sahm
Jefferies Financial Group Inc. Acquires New Holdings in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Rhenman & Partners Asset Management AB Purchases 45,000 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Trading Systems Reacting to (GPCR) Volatility - Stock Traders Daily
Research Analysts Offer Predictions for GPCR Q1 Earnings - Defense World
HC Wainwright Issues Negative Estimate for GPCR Earnings - MarketBeat
Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear? - TradingView
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million - AOL.com
GPCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Handelsbanken Fonder AB Sells 212,000 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position - AOL.com
Structure Therapeutics (NASDAQ:GPCR) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright raises Structure Therapeutics price target on competitive positioning - Investing.com
Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Sold by Monashee Investment Management LLC - MarketBeat
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
Did New Shelf Registration and Oral GLP-1 Progress Just Shift Structure Therapeutics' (GPCR) Investment Narrative? - Sahm
Structure Therapeutics (NASDAQ:GPCR) Upgraded by Wall Street Zen to Hold Rating - Defense World
Structure Therapeutics shares could rise on obesity drug data, Cantor says - Investing.com India
Structure Therapeutics (NASDAQ:GPCR) Price Target Cut to $113.00 by Analysts at Citizens Jmp - MarketBeat
Citizens cuts Structure Therapeutics stock price target on pipeline expansion - Investing.com
Structure Therapeutics (NASDAQ:GPCR) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Structure Therapeutics Inc. SEC 10-K Report - TradingView
Structure Therapeutics (NASDAQ: GPCR) turns Q4 profit as obesity pipeline advances - Stock Titan
Obesity pill aleniglipron trims 15% weight as maker turns quarterly profit - Stock Titan
Private Capital Advisors Inc. Buys New Shares in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Alpha Tau Medical Ltd (DRTS) and Oric Pharmaceuticals (ORIC) - The Globe and Mail
How Structure Therapeutics Inc. (GPCR) Affects Rotational Strategy Timing - Stock Traders Daily
Analysts’ Top Healthcare Picks: Ascendis Pharma (ASND), BioNTech SE (BNTX) - The Globe and Mail
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026 - TradingView
Structure Therapeutics Inc. (GPCR): Analyst Consensus Points To A 60% Upside Potential - DirectorsTalk Interviews
GPCRStructure Therapeutics Inc ADR Latest Stock News & Market Updates - Stock Titan
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), Guardant Health (GH) and PTC Therapeutics (PTCT) - The Globe and Mail
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake - AOL.com
Structure Therapeutics (GPCR) Gained from Favorable Clinical Data - Finviz
Aberdeen Group plc Boosts Stock Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World
Structure Therapeutics (GPCR) Projected to Post Earnings on Thursday - MarketBeat
Structure Therapeutics surges on phase 2 data for GLP-1 pill aleniglipron - MSN
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Galapagos (GLPG) and West Pharmaceutical Services (WST) - The Globe and Mail
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition? - TradingView
Readystate Asset Management LP Increases Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Palvella Therapeutics (PVLA) - The Globe and Mail
BVF group discloses 4.9% Structure Therapeutics (GPCR) holding - Stock Titan
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Short Interest Down 17.8% in January - MarketBeat
(GPCR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
FY2030 Earnings Forecast for GPCR Issued By HC Wainwright - MarketBeat
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), CSL (CMXHF) - The Globe and Mail
Structure Therapeutics Inc. Sponsored ADR $GPCR Stake Lessened by Federated Hermes Inc. - MarketBeat
Assessing Structure Therapeutics (GPCR) Valuation As Oral Obesity Drug GSBR-1290 Advances In Phase 2 - Sahm
Principal Financial Group Inc. Decreases Stock Holdings in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics’ Oral Obesity Drug Enters Phase 2 As Investor Focus Grows - Sahm
Structure Therapeutics (NASDAQ:GPCR) Shares Down 10.7%Here's Why - MarketBeat
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):